The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
Anne Marie Morse, DO1; Atul Malhotra, MD2; Lucie Barateau, MD, PhD3; David T. Plante, MD, PhD4; Zachary Cline, PhD5; Christopher DeFelice5; Maria Picone5; Jacqueline Brooks, MBBCh, MRCPsych6
1Geisinger Commonwealth School of Medicine, Geisinger Medical Center, Janet Weis Children’s Hospital, Danville, PA, USA; 2University California San Diego, La Jolla, CA, USA; 3Sleep-Wake Disorders Center, Department of Neurology, Gui-de-Chauliac Hospital, Institute for Neurosciences of Montpellier INM, INSERM, University of Montpellier, Montpellier, France; 4University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; 5TREND Community, Philadelphia, PA, USA; 6Alkermes, Inc., Waltham, MA, USA*
